Industrias Bachoco, S.A.B. de C.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IDBHF research report →
Price Chart
About the company
Established in 1952 and headquartered in Celaya, Mexico, Industrias Bachoco, S. A. B.
- CEO
- Ernesto Salmon Castelo
- IPO
- 2016
- Employees
- 39,812
- HQ
- Celaya, GJ, MX
Get TickerSpark's AI analysis on IDBHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $30.00M
- P/E
- 12.67
- Fwd P/E
- 0.09
- PEG
- -0.33
- P/S
- 0.54
- P/B
- 0.92
- EV/EBITDA
- 4.65
- Div Yield
- 1.93%
- Gross Margin
- 15.71%
- Op Margin
- 6.91%
- Net Margin
- 4.22%
- ROE
- 7.40%
- ROIC
- 7.24%
Latest fiscal year · YoY change
- Revenue
- $4.76B-13.9%
- Gross Profit
- $972.52M+10.0%
- Op Income
- $465.49M
- Net Income
- $442.58M+62.1%
- EPS
- $0.74+60.9%
- OCF Growth
- +128.2%
- FCF Growth
- +118.6%
- 52W High
- $5.00
- 52W Low
- $0.00
- 50D MA
- $0.05
- 200D MA
- $0.05
- Beta
- 0.18
- RSI (14)
- 0
- Avg Volume
- 314
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Bachoco posted strong 25.9% revenue growth in Q1 2022, but higher grain and soybean costs compressed margins and management said near-term volatility remains elevated.· April 29, 2022
- Net sales rose 25.9% year over year to Mex$24,367 million, helped by pricing and the consolidation of RYC Alimentos.
- Cost of sales increased 27.1%, outpacing revenue growth and pressuring profitability.
- Gross margin declined to 21.0% from 21.8%, and EBITDA margin fell to 14.4% from 15.1%.
- Management said chicken demand should stay supported because it remains the cheapest protein, even if higher prices can weigh on consumption.
- Executives highlighted strong biosecurity and diversified sourcing amid bird flu concerns, and said the company sees no operational change tied to the proposed tender offer process.
First-quarter 2022 net sales were Mex$24,367 million, up Mex$5,009.4 million or 25.9% from Mex$19,357.6 million a year ago. Cost of sales rose 27.1% to Mex$19,240.5 million, leading to gross profit of Mex$5,126.5 million and gross margin of 21.0%, versus Mex$4,218 million and 21.8% in Q1 2021. SG&A was Mex$1,999.1 million, or 8.2% of sales, operating margin was 12.9%, EBITDA margin was 14.4% versus 15.1%, and net income was Mex$2,128 million, with net margin of 8.7%; EPS was Mex$3.60 versus Mex$3.51 last year. CapEx was Mex$915.2 million, up from Mex$555.7 million, partly due to RYC Alimentos integration, and the annual shareholders’ meeting approved a cash dividend of Mex$1.64 per share, or Mex$19.68 per ADR. The company did not provide formal next-quarter or full-year financial guidance, but said it expects commodity volatility to remain high, with pricing likely to stay strong while raw-material costs are difficult to predict.
Rodolfo Ramos framed the quarter as a period of significant cost pressure from corn and soybean meal, but said the company focused on what it can control: efficiency, sales mix, market share, and integrating RYC Alimentos. He emphasized improvements in the U.S. operation after prior labor shortages, and said Bachoco has been able to offset some input inflation through hedging, operating efficiencies, and pricing. His tone was cautious but constructive, repeatedly noting uncertainty in commodity markets while expressing confidence in the company’s discipline and ability to keep profitability relatively normalized over time.
Daniel Salazar quantified the quarter’s performance and stressed that revenue growth was not enough to offset inflation in inputs. He cited net sales of Mex$24,367 million, gross profit of Mex$5,126.5 million, gross margin of 21.0%, SG&A of Mex$1,999.1 million, EBITDA margin of 14.4%, net income of Mex$2,128 million, and EPS of Mex$3.60. He also noted net financial expenses of Mex$235.7 million versus net financial income of Mex$319.6 million last year, driven by peso movements, and CapEx of Mex$915.2 million, with part of the increase tied to RYC Alimentos assets. On capital returns, he said the annual meeting approved a cash dividend of Mex$1.64 per share, or Mex$19.68 per ADR.
Analysts focused on Bachoco’s long-term growth and margin trajectory, the impact of inflation on demand, bird flu exposure, the government’s anti-inflation plan, and the proposed tender offer by the controlling family. Management said long-term EBITDA should remain “very close” to historical levels and that pricing should remain strong, but raw-material costs are hard to forecast. On demand, they said chicken should hold up because it is the cheapest protein, while also noting the market may be tighter because of constrained meat supply and hatchability issues. On the tender offer, management said it is an external process, the company has no additional information yet, and the board’s independent directors would be the ones to opine once the offer is formally authorized; they also said the process could take one to two months at least.
The bull case from this call is that Bachoco is still growing revenue quickly and passing through inflation through pricing, while also gaining from RYC Alimentos and operational improvements in the U.S. Management said chicken remains the cheapest protein, which should support demand even in a higher-price environment. They also pointed to hedging, efficiency gains, and a disciplined balance sheet/capex approach as tools to stabilize profitability.
The main bear case is that input inflation is still severe, with cost of sales up 27.1% and margin compression already visible in gross and EBITDA margins. Management was explicit that commodity volatility is hard to predict and that the benefit from hedging will eventually diminish. There is also uncertainty around bird flu, government inflation measures, and the pending tender offer process, all of which could add noise around the stock and the business outlook.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 2.4%
- Shares Outstanding
- 600.00M
- Float Shares
- 14.23M
Our IDBHF coverage
Recent articles, reports, and earnings notes.
No research on IDBHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IDBHF report →